WASHINGTON – A diabetes medicine poised to win Food and Drug Administration approval sharply increases the risk of heart problems, strokes and death, researchers reported Thursday in an analysis that raises pointed new questions about the agency’s handling of drug safety issues. The drug, Pargluva,… Read More
Comments for: Diabetes drug poses high risk, report says
Diabetes drug poses high risk, report says
You may also like
Diabetes drug poses high risk, report says